Effect Of Nayanamruta Lauham On Drishtipatalagata Vyadhi With Reference To Age Related Macular Degeneration A Clinical Study

This is a prospective, parallel arm, open-label clinical study designed to evaluate the effect of Nayanamruta Lauham in the management of Drishtipatalagata Vyadhi with reference to Age-Related Macular Degeneration (AMD). A total of 60 participants diagnosed with non-neovascular AMD will be enrolled. Eligible participants will receive Nayanamruta Lauham as per protocol for a duration of 3 months (12 weeks) with follow-up assessments at baseline, 4 weeks, 8 weeks, and 12 weeks. The primary outcome is the change in Best Corrected Visual Acuity (BCVA) from baseline to 12 weeks. Secondary outcomes include changes in contrast sensitivity, central macular thickness (OCT), metamorphopsia (Amsler grid), and vision-related quality of life (NEI VFQ-25). Safety assessments will include monitoring of adverse events and routine laboratory investigations. The study aims to explore the clinical efficacy and safety of Nayanamruta Lauham as an Ayurvedic intervention for improving visual function in patients with dry AMD.